Use of products in capital punishment

Hikma aims to improve lives by providing patients with access to high quality, affordable medicines.  Our medicines are used thousands of times a day around the world to treat illness and save lives.

We object in the strongest possible terms to the use of any of our products for the purpose of capital punishment. Not only is it contrary to the intended label use(s) for the products, but it is also inconsistent with our values and mission of improving lives by providing quality, affordable healthcare to patients.

While none of our products should ever be used for the purpose of capital punishment, in the table below, we have identified certain products that carry heightened risk of misuse for lethal injection protocols.  Accordingly, to prevent these products from being used for the purpose of capital punishment, we will not accept orders for these products directly from any Departments of Correction or correctional facilities in the United States, unless accompanied by an original, raised seal copy of an affidavit signed by the state attorney general (or governor), certifying under penalty of perjury that the product(s) will not be used for capital punishment.  Further, we will only sell these same drugs to pre-selected commercial customers who agree that they will not then sell them to Departments of Corrections/correctional facilities, or to secondary distributors or retail pharmacies.  

We vigorously monitor the distribution of these products and support industry serialization efforts that will help enhance these controls while continuing to promote our values and mission. 

Further, transparency is one of our core values, and as such we object to attempts by any entity, person or state to obscure or hide the source of products for lethal injection. It is imperative that we are not impeded from protecting patient health and the integrity of our products and our supply chain. 

Name / Description
HYDROMORPHONE 2MG/ML  VIAL X 25
HYDROMORPHONE 40MG/20ML VIAL X 1
MIDAZOLAM 10MG/10ML VIAL X 10
MIDAZOLAM 10MG/2ML  VIAL X 10
MIDAZOLAM 10MG/2ML  VIAL X 25
MIDAZOLAM 2MG/2ML  VIAL X 10
MIDAZOLAM 2MG/2ML  VIAL X 25
MIDAZOLAM 50MG/10ML VIAL X 10
MIDAZOLAM 5MG/5ML VIAL X10
MIDAZOLAM 5MG/ML   VIAL X 25
PHENOBARBITAL 130MG/ML  VIAL X 25
PHENOBARBITAL 65MG/ML  VIAL X 25
ETOMIDATE 20 MG/10 ML VIAL X 10
ETOMIDATE 40 MG/20 ML VIAL X 10
Fentanyl Citrate Injection, USP  C-II (AMPULS) 100 mcg / 2 mL
Fentanyl Citrate Injection, USP  C-II   (AMPULS) 250 mcg / 5 mL
Fentanyl Citrate Injection, USP  C-II   (AMPULS) 1000 mcg / 20 mL
Fentanyl Citrate Injection, USP  C-II   (VIALS) 100 mcg / 2 mL
Fentanyl Citrate Injection, USP  C-II   (VIALS) 250 mcg / 5 mL
Fentanyl Citrate Injection, USP  C-II   (VIALS) 1000 mcg / 20 mL
Fentanyl Citrate Injection, USP  C-II   (VIALS) 2500 mcg / 50 mL
Ativan Injection (Lorazepam Injection, USP) C-IV 20 mg / 10 mL
Ativan Injection (Lorazepam Injection, USP) C-IV 40 mg / 10 mL
Ativan Injection (Lorazepam Injection, USP) C-IV 2 mg / mL
Ativan Injection (Lorazepam Injection, USP) C-IV 4 mg / mL
Lorazepam Injection, USP C-IV 20 mg / 10 mL
Lorazepam Injection, USP C-IV 40 mg / 10 mL
Lorazepam Injection, USP C-IV 2 mg / mL
Lorazepam Injection, USP C-IV 4 mg / mL
Lorazepam Injection, USP C-IV (NOVAPLUS) 2 mg / mL
Lorazepam Injection, USP C-IV (NOVAPLUS) 4 mg / mL
Lorazepam Injection, USP C-IV (NOVAPLUS) 20 mg / 10 mL
Lorazepam Injection, USP C-IV (NOVAPLUS) 40 mg / 10 mL
Lorazepam Injection, USP C-IV (PRORX) 2 mg / mL